Medicalgorithmics S.A.
MDG.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 24 | PLN 43 | PLN 63 | PLN 48 |
| % Growth | -44.3% | -31.3% | 29.7% | – |
| Cost of Goods Sold | PLN 4 | PLN 26 | PLN 12 | PLN 7 |
| Gross Profit | PLN 20 | PLN 17 | PLN 50 | PLN 113 |
| % Margin | 84.9% | 39.3% | 80.3% | 234.1% |
| R&D Expenses | PLN 0 | PLN 1 | PLN 3 | PLN 3 |
| G&A Expenses | PLN 4 | PLN 13 | PLN 5 | PLN 31 |
| SG&A Expenses | PLN 4 | PLN 13 | PLN 5 | PLN 32 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | PLN 33 | PLN 2 | -PLN 0 | PLN 83 |
| Operating Expenses | PLN 37 | PLN 17 | PLN 8 | PLN 118 |
| Operating Income | -PLN 17 | PLN 0 | PLN 17 | -PLN 4 |
| % Margin | -68.9% | 1% | 27.4% | -9.1% |
| Other Income/Exp. Net | PLN 1 | -PLN 1 | PLN 8 | PLN 3 |
| Pre-Tax Income | -PLN 16 | -PLN 0 | PLN 25 | -PLN 7 |
| Tax Expense | PLN 0 | PLN 0 | -PLN 0 | -PLN 0 |
| Net Income | -PLN 16 | -PLN 1 | -PLN 12 | -PLN 181 |
| % Margin | -67% | -1.3% | -18.9% | -373.6% |
| EPS | -1.62 | -0.11 | -2.08 | -39.73 |
| % Growth | -1,372.7% | 94.7% | 94.8% | – |
| EPS Diluted | -1.62 | -0.06 | -2.08 | -39.73 |
| Weighted Avg Shares Out | 10 | 5 | 6 | 5 |
| Weighted Avg Shares Out Dil | 10 | 5 | 6 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 1 | PLN 0 | PLN 0 |
| Interest Expense | PLN 0 | PLN 0 | PLN 0 | PLN 1 |
| Depreciation & Amortization | PLN 4 | PLN 2 | PLN 4 | PLN 4 |
| EBITDA | -PLN 12 | PLN 2 | PLN 30 | -PLN 2 |
| % Margin | -49.9% | 5.2% | 47.4% | -4.6% |